Greg Pyszczymuka

Greg Pyszczymuka

Corporate Officer/Principal bij AYTU BIOPHARMA, INC.

Vermogen: 64 661 $ op 30-04-2024

Health Technology
Consumer Services

Oorsprong van het eerstegraads netwerk van Greg Pyszczymuka

EntiteitType entiteitIndustrie
Subsidiary Pharmaceuticals: Major 19
Public Company Pharmaceuticals: Major 12

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Greg Pyszczymuka via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
AMGEN INC. Pharmaceuticals: Major

Joshua Disbrow

Corporate Officer/Principal

Pharmaceuticals: Major

John M. Limongelli

Corporate Officer/Principal

Life/Health Insurance

John M. Limongelli

Corporate Secretary

INCYTE CORPORATION Pharmaceuticals: Major

Mark Oki

Corporate Officer/Principal

CYBERONICS, INC. Medical Specialties

Joshua Disbrow

Sales & Marketing

PHARMACYCLICS, INC. Pharmaceuticals: Major

Mark Oki

Comptroller/Controller/Auditor

VIVUS, INC. Pharmaceuticals: Major

Mark Oki

Director of Finance/CFO

ZYNEX, INC. Medical Specialties

Joshua Disbrow

Director/Board Member

Biotechnology

John M. Limongelli

General Counsel

LIPOSCIENCE INC Medical Specialties

Joshua Disbrow

Sales & Marketing

ALEXZA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Mark Oki

Director of Finance/CFO

Medical Specialties

John Donofrio

Treasurer

Pharmaceuticals: Major

Jarrett Disbrow

Joshua Disbrow

John Donofrio

Founder

Chief Operating Officer

Chief Operating Officer

INNOVUS PHARMACEUTICALS INC Pharmaceuticals: Other

Vivian Liu

Joshua Disbrow

Ryan J. Selhorn

Chief Executive Officer

Chief Executive Officer

Director of Finance/CFO

NVN LIQUIDATION, INC. Pharmaceuticals: Major

John Donofrio

Chief Operating Officer

Miscellaneous Commercial Services

John M. Limongelli

Comptroller/Controller/Auditor

GSK PLC Pharmaceuticals: Major

Jarrett Disbrow

Joshua Disbrow

John Donofrio

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Wake Forest University College/University

Joshua Disbrow

Masters Business Admin

Miscellaneous Commercial Services

John M. Limongelli

Corporate Officer/Principal

North Carolina State University College/University

Jarrett Disbrow

Joshua Disbrow

John Donofrio

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

DePaul University College/University

Alan L. Heller

James Robinson

Masters Business Admin

Undergraduate Degree

XERIS BIOPHARMA HOLDINGS, INC. Biotechnology

Beth Hecht

John Schmid

General Counsel

Director/Board Member

University of California, Berkeley College/University

Vivian Liu

Bryant Fong

Undergraduate Degree

Undergraduate Degree

TREVENA, INC. Pharmaceuticals: Major

John M. Limongelli

Chief Administrative Officer

CIGNA Managed Health Care

John M. Limongelli

Corporate Secretary

Moravian College College/University

Steven M. Lutz

Undergraduate Degree

Pharmaceuticals: Major

Steven M. Lutz

Corporate Officer/Principal

CORNERSTONE THERAPEUTICS, INC. Pharmaceuticals: Major

Steven M. Lutz

Founder

San Jose State University College/University

Mark Oki

Undergraduate Degree

Temple University (Pennsylvania) College/University

John M. Limongelli

Graduate Degree

Alliance Medical Ministry

John Donofrio

Director/Board Member

AMPIO PHARMACEUTICALS, INC. Pharmaceuticals: Major

Joshua Disbrow

Chief Operating Officer

Medical Specialties

Joshua Disbrow

Director/Board Member

Pharmaceuticals: Major

John Donofrio

Corporate Officer/Principal

Edward Weck & Co.

John Donofrio

Corporate Officer/Principal

Pharmaceuticals: Major

John Donofrio

Director of Finance/CFO

Statistieken

Internationaal

Verenigde Staten 43
Verenigd Koninkrijk 2
Singapore 2
Duitsland 2

Sectoraal

Health Technology 30
Consumer Services 9
Commercial Services 4
Finance 2
Health Services 2

Operationeel

Director/Board Member 90
Corporate Officer/Principal 55
Independent Dir/Board Member 33
Director of Finance/CFO 28
Undergraduate Degree 24
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU